Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 56-62, 15 January 2008

Functional characterization of a novel mutation in TITF-1 in a patient with benign hereditary chorea

  • Claudia Provenzano

      Affiliations

    • Institute of Neurobiology and Molecular Medicine, National Council Research, Via Fosso del Cavaliere 100, 00133 Rome, Italy
    • These two authors have contributed equally to this work.
  • ,
  • Liana Veneziano

      Affiliations

    • Institute of Neurobiology and Molecular Medicine, National Council Research, Via Fosso del Cavaliere 100, 00133 Rome, Italy
    • These two authors have contributed equally to this work.
  • ,
  • Richard Appleton

      Affiliations

    • Royal Liverpool Children's Hospital Eaton Rd, Liverpool L12-2AP, United Kingdom
  • ,
  • Marina Frontali

      Affiliations

    • Institute of Neurobiology and Molecular Medicine, National Council Research, Via Fosso del Cavaliere 100, 00133 Rome, Italy
  • ,
  • Donato Civitareale

      Affiliations

    • Institute of Neurobiology and Molecular Medicine, National Council Research, Via Fosso del Cavaliere 100, 00133 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 300649934225; fax: +39 300649934257.

Received 30 April 2007; received in revised form 25 June 2007; accepted 28 June 2007.

Abstract 

Benign hereditary chorea (BHC) is an autosomal dominant disorder of early onset characterised by non progressive choreic movements with normal cognitive function occasionally associated with hypothyroidism and respiratory problems. Numerous pieces of evidence link BHC with TITF-1/NKX2.1 gene mutations. We studied a patient with a familial benign hereditary chorea and normal thyroid and respiratory function. Sequence analysis of TITF-1 revealed the presence of a heterozygous C>T substitution at nucleotide 532, predicted to change an arginine (CGA) with a stop codon (TGA) at position 178 (R178X). A functional analysis shows that the mutated TTF-1 is not binding DNA, nor activating the canonical thyroid target gene promoter or interfering with the ability of wild type TTF-1 to activate transcription. In addition, the mutated protein is predominantly cytoplasmic, rather than nuclear as in the case of the wild type TTF-1. Thus, we have identified a new mutation in the TTF-1 coding gene in a patient with benign hereditary chorea. The results show that the mutation leads to a haploinsufficiency of TITF-1 and opens the question of genotype/phenotype correlation.

Keywords: TTF-1, NKX2.1, Benign hereditary chorea, BHC, Haploinsufficiency

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(07)00488-1

doi:10.1016/j.jns.2007.06.056

Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 56-62, 15 January 2008